Technical Information Specialist
Epidemiology Branch — Environmental Diseases and Medicine Program
Division of Intramural Research, National Institute of Environmental Health Sciences
Ms. Ragan is alternate project officer for the Treatment of Lead-exposed Children (TLC) trial, a multi-center randomized, controlled clinical trial of oral chelation therapy to prevent lead-induced disorder of growth, behavior and cognitive development in toddlers. The TLC has randomized 780 children between 13–33 months of age with blood leads of 20–45 µg/dL and is following them for 3 years after treatment. Ms. Ragan serves on both the Coordinator's Subcommittee and the Environmental Subcommittee for the TLC trial.
Ms. Ragan joined Walter Rogan (Epidemiology Branch, NIEHS) and Beth Gladen (Statistics Branch, NIEHS) as a co-investigator in a puberty followup of their cohort study of North Carolina children who were exposed to background levels of PCBs and DDT. In this 5-year followup study, the children completed annual self-assessments of their pubertal status with questionnaires that include simplified line drawings of the Tanner stages. The study indicated that transplacental exposures to background levels of PCBs and DDE affected height and weight of boys and girls at puberty.
Ms. Ragan also designs and maintains several Institute web pages, including those for the Treatment of Lead-exposed Children trial, Epidemiology Branch, and the NIEHS Institutional Review Board (IRB).
Source: NIEHS Epidemiology Branch — N. Beth Ragan (archived June 9, 2000)